论文部分内容阅读
目的:分析和探讨雷贝拉唑与奥美拉唑在治疗反流性食管炎过程中的临床效果。方法:选用了我院在2012年1月-2013年1月接收的68例反流性食管炎患者作为研究对象,将其随机分为实验组和对照组,对照组患者给予奥美拉唑治疗,实验组患者给予雷贝拉唑治疗,比较两组患者的治疗效果。结果:实验组患者的治疗效果、伤口愈合率及不良反应情况都明显优于对照组,并且两组之间的差异具有统计学意义(P<0.05)。结论:雷贝拉唑不仅能够有效的缓解反流性食管炎的各项临床症状,而且还能促进伤口的愈合,避免不良反应的出现,因此值得在临床上予以推广。
Objective: To analyze and discuss the clinical effect of rabeprazole and omeprazole in the treatment of reflux esophagitis. Methods: Sixty-eight patients with reflux esophagitis received in our hospital from January 2012 to January 2013 were randomly divided into experimental group and control group, while patients in control group were treated with omeprazole , Rabeprazole treatment group patients, the treatment effect of two groups were compared. Results: The therapeutic effect, wound healing rate and adverse reactions in the experimental group were significantly better than those in the control group, and the difference between the two groups was statistically significant (P <0.05). Conclusion: Rabeprazole not only can effectively alleviate the clinical symptoms of reflux esophagitis, but also promote the healing of wounds and avoid the appearance of adverse reactions. Therefore, it is worth to be popularized clinically.